## Pathophysiology of Neonatal Hypoglycemia in GDM ### The Hyperglycemia-Hyperinsulinemia Cycle **Key Point:** Maternal hyperglycemia in GDM leads to a **cascade of fetal metabolic derangements** that culminates in neonatal hypoglycemia. ### Step-by-Step Mechanism 1. **Maternal Hyperglycemia** - Elevated maternal blood glucose crosses the placenta via GLUT1 transporters - Fetus is exposed to chronically elevated glucose 2. **Fetal Hyperglycemia** - Fetal blood glucose rises in response to maternal glucose - Stimulates fetal pancreatic β-cells 3. **Fetal Hyperinsulinemia** - Excessive fetal insulin secretion (insulin does NOT cross the placenta) - Insulin acts as a **fetal growth hormone** → macrosomia - Insulin suppresses hepatic gluconeogenesis and glycogenolysis 4. **Neonatal Hypoglycemia (Post-Delivery)** - At birth, umbilical cord is clamped → maternal glucose supply abruptly stops - Neonate still has **high circulating insulin** (takes 4–6 hours to decline) - High insulin suppresses glucose production and promotes glucose utilization - Result: **Severe hypoglycemia** in the first hours of life **High-Yield:** This is why neonates of GDM mothers require **early feeding** and **frequent glucose monitoring** in the first 24–48 hours. ### Clinical Consequences **Mnemonic: CHOPS** — Complications of Hyperinsulinemia in Offspring of Pregnant diabetics - **C**ardiomyopathy (transient) - **H**ypoglycemia - **O**besity (later in life) - **P**olycythemia - **S**houlder dystocia (macrosomia) **Clinical Pearl:** Neonatal hypoglycemia in GDM is **transient and self-limiting** if managed promptly with feeding or IV dextrose. It usually resolves within 24–48 hours as fetal insulin levels normalize. [cite:Cunningham & Leveno OB/GYN, Harrison 21e Ch 427]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.